Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven node-positive breast cancer
SR Tee, LA Devane, D Evoy, J Rothwell… - Journal of British …, 2018 - academic.oup.com
Background Neoadjuvant chemotherapy for breast cancer has the potential to achieve a
pathological complete response in up to 40 per cent of patients, converting disease that was …
pathological complete response in up to 40 per cent of patients, converting disease that was …
[HTML][HTML] Sentinel lymph node methods in breast cancer
F Giammarile, S Vidal-Sicart, D Paez, O Pellet… - Seminars in Nuclear …, 2022 - Elsevier
Breast cancer is the most frequent cancer diagnosed in women worldwide. Accurate lymph
node staging is essential for both prognosis (of early-stage disease) and treatment (for …
node staging is essential for both prognosis (of early-stage disease) and treatment (for …
[HTML][HTML] Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast …
ABSTRACT The 14th St Gallen International Breast Cancer Conference (2015) reviewed
substantial new evidence on locoregional and systemic therapies for early breast cancer …
substantial new evidence on locoregional and systemic therapies for early breast cancer …
How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study
A Mamtani, AV Barrio, TA King, KJ Van Zee… - Annals of surgical …, 2016 - Springer
Background In breast cancer patients with nodal metastases at presentation, false-negative
rates lower than 10% have been demonstrated for sentinel node biopsy (SLNB) after …
rates lower than 10% have been demonstrated for sentinel node biopsy (SLNB) after …
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox
Primary systemic therapy is increasingly used in the treatment of patients with early-stage
breast cancer, but few guidelines specifically address optimal locoregional therapies …
breast cancer, but few guidelines specifically address optimal locoregional therapies …
Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at …
HEH Chehade, H Headon, O El Tokhy… - The American Journal of …, 2016 - Elsevier
BACKGROUND The use of sentinel lymph node biopsy (SLNB) following neoadjuvant
chemotherapy (NAC) in patients presenting with clinically positive lymph nodes remains …
chemotherapy (NAC) in patients presenting with clinically positive lymph nodes remains …
Axillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre …
EJ Diego, PF McAuliffe, A Soran, KP McGuire… - Annals of surgical …, 2016 - Springer
Background Neoadjuvant chemotherapy (NAC) downstages axillary disease in 55% of node-
positive (N1) breast cancer. The feasibility and accuracy of sentinel lymph node biopsy …
positive (N1) breast cancer. The feasibility and accuracy of sentinel lymph node biopsy …
[HTML][HTML] The feasibility and accuracy of sentinel lymph node biopsy in initially clinically node-negative breast cancer after neoadjuvant chemotherapy: a systematic …
C Geng, X Chen, X Pan, J Li - PloS one, 2016 - journals.plos.org
Background With the increased use of neoadjuvant chemotherapy (NAC) in breast cancer,
the timing of sentinel lymph node biopsy (SLNB) has become increasingly important. In this …
the timing of sentinel lymph node biopsy (SLNB) has become increasingly important. In this …
Oncologic safety of sentinel lymph node biopsy alone after neoadjuvant chemotherapy for breast cancer
SM Wong, M Basik, L Florianova, R Margolese… - Annals of Surgical …, 2021 - Springer
Background The oncologic safety of sentinel lymph node biopsy (SLNB) alone for clinically
node-positive (cN1–2) patients who convert to pathologic node-negativity (ypN0) after …
node-positive (cN1–2) patients who convert to pathologic node-negativity (ypN0) after …
Omission of axillary lymph node dissection is associated with inferior survival in breast cancer patients with residual N1 nodal disease following neoadjuvant …
Background The appropriateness of substituting sentinel lymph node dissection (SLND) and
regional nodal irradiation (RNI) for axillary lymph node dissection (ALND) in patients with …
regional nodal irradiation (RNI) for axillary lymph node dissection (ALND) in patients with …